$SPKB News
Last published 3y ago
- 3y agoSPKBSilver Spike Acquisition Corp II Announces Redemption of Class A Ordinary SharesGlobeNewswireNEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Silver Spike Acquisition Corp II (the "Company") today announced that it will redeem all of its outstanding Class A ordinary shares (the "Class A Ordinary Shares"),
- 4y agoSPKBSPKBUEleusis and Silver Spike Acquisition Corp. II Mutually Agree to Terminate Business Combination AgreementBusiness WireEleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II ("Silver Spike II" or "SPKB") (NASDAQ:SPKB), a publicly traded special purpose acquisition company ("SPAC
- 4y agoSPKBEleusis Announces Notice of Allowance for US Patent Application with Claims Covering Lead Drug Candidate ELE-PsiloBusiness WireEleusis Holdings Ltd announced today it has received a Notice of Allowance for its proprietary psilocin salt form and accompanying formulations from the US Patent and Trademark Office. This salt form and formulations are being developed as Eleusis' lead
- 4y agoCRHCDMKBAEXTNSPKBMoore Kuehn Encourages SPKB, DMKBA, CRHC, and EXTN Investors to Contact Law FirmGlobeNewswireNEW YORK, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair t
- 4y agoSPKBSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Silver Spike Acquisition Corp. II (Nasdaq - SPKB)PR NewswireBALA CYNWYD, Pa., Jan. 20, 2022 /PRNewswire/ -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Silver Spike Acquisition Corp. II ("Silver Spike II" or the "Company")(Nasdaq – SPKB)
- 4y agoMAPSSPKBSPKBUSPKBWPsychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. IIBusiness WireBusiness combination with Silver Spike Acquisition Corp. II (NASDAQ:SPKB) expected to generate gross proceeds of up to $288 million and implies a combined enterprise value of $446 million Eleusis pioneers the development of psychedelic drug candid
- 5y agoSPKBSilver Spike Acquisition Corp II Announces Pricing of $250 Million Initial Public OfferingBusiness WireNEW YORK--(BUSINESS WIRE)--Silver Spike Acquisition Corp II (the “Company”) announced today that it priced its initial public offering of 25,000,000 units at $10.00 per unit. The units are expected to be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “SPKBU” beginning on March 11, 2021. Each unit consists of one Class A ordinary share and one-fourth of one redeema ...